Boehringer-Zealand's obesity drug shows promise in cutting visceral, liver fat Boehringer Ingelheim said on Sunday its experimental obesity drug cut visceral and liver fat while minimizing loss of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results